Last reviewed · How we verify

NCT03890276: HMS-ECL&B

Field Study of Health Worker Training on Helping Mothers Survive Module 'Essential Care for Labor & Birth' in Zanzibar

Completed NA Last updated 6 November 2019
What this trial tests

NA trial testing HMS EL&C training module in Parturition in 120 participants. Completed in 15 May 2019.

Timeline
1 May 2019
Primary endpoint
15 May 2019
15 May 2019

Quick facts

Lead sponsorJhpiego
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposeother
Enrollment120
Start date1 May 2019
Primary completion15 May 2019
Estimated completion15 May 2019
Sites6 locations across Tanzania

Drugs / interventions tested

Conditions studied

Sponsor

Jhpiego — full company profile →

Who can join

18 and older, any sex, with Parturition. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this study is to ensure that the training materials and methods for the training module Helping Mothers Survive Essential Care for Labor \& Birth (ECL\&B) are usable and acceptable by trainers and healthcare providers in Zanzibar. Findings from this study will be used to improve the modules and validate the trainee assessments. This study also compares provider learning outcomes in the training module delivered with and without video demonstration. Focusing on the first two phases of the Kirkpatrick model, the field validation will answer the following research questions: 1. How acceptable and appropriate for adequate teaching and learning is the training module? 2. What is the gain in knowledge, clinical decision-making, communication, and psychomotor skills of the trainees from pre to post-training assessment? (immediate learner outcomes) 3. Is there a difference in immediate learner outcomes in training where video clips are used during training to supplement live trainer demonstration compared to training where video is not used as a supplement?

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Jhpiego trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03890276.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing